Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Pediatr Dermatol ; 2023 Nov 29.
Article in English | MEDLINE | ID: mdl-38018255

ABSTRACT

We describe a case of congenital syphilis in an adopted infant with a unique dermatologic presentation of scalp granulomas, along with lymphadenopathy, anemia, and elevated liver transaminases. To our knowledge, this cutaneous morphology has not been previously reported in the literature. This case highlights the varied clinical presentation of congenital syphilis and the diagnostic challenge it poses for clinicians, especially in the context of unknown prenatal history/unknown risk factors, or if syphilis is acquired during pregnancy after routine screening is performed. As the incidence of congenital syphilis has more than tripled in recent years, this diagnosis should be considered when a neonate or infant presents with unexplained skin nodules.

2.
Pediatr Dermatol ; 39(5): 823-824, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35522122

ABSTRACT

A 12-year-old boy presented with a 2-week history of persistent pruritic edematous plaques one day after he received the first dose of the BNT162b2 COVID-19 mRNA vaccine. A skin biopsy showed urticarial dermatitis with tissue eosinophilia consistent with a diagnosis of vaccine-associated eosinophilic cellulitis, with polyethylene glycol as a potential trigger.


Subject(s)
COVID-19 Vaccines , COVID-19 , Eosinophilia , BNT162 Vaccine , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Cellulitis/diagnosis , Cellulitis/etiology , Child , Eosinophilia/diagnosis , Humans , Male , Polyethylene Glycols , Vaccination , Vaccines, Synthetic , mRNA Vaccines
4.
JAMA Dermatol ; 2021 06 16.
Article in English | MEDLINE | ID: mdl-34132754

ABSTRACT

Importance: A 2010 prospective study of 108 infants estimated the incidence of PHACE (posterior fossa malformations, hemangioma, arterial anomalies, cardiac defects, eye anomalies) syndrome to be 31% in children with facial infantile hemangiomas (IHs) of at least 22 cm2. There is little evidence regarding the associations among IH characteristics, demographic characteristics, and risk of PHACE syndrome. Objectives: To evaluate demographic characteristics and comorbidities in a large cohort of patients at risk for PHACE syndrome and assess the clinical features of large head and neck IH that may be associated with a greater risk of a diagnosis of PHACE syndrome. Design, Setting, and Participants: This multicenter, retrospective cohort study assessed all patients with a facial, head, and/or neck IH who were evaluated for PHACE syndrome from August 1, 2009, to December 31, 2014, at 13 pediatric dermatology referral centers across North America. Data analysis was performed from June 15, 2017, to February 29, 2020. Main Outcomes and Measures: The main outcome was presence or absence of PHACE syndrome. Data included age at diagnosis, sex, patterns of IH presentation (including size, segment location, and depth), diagnostic procedures and results, and type and number of associated anomalies. Results: A total of 238 patients (mean [SD] age, 2.96 [4.71] months; 184 [77.3%] female) were included in the analysis; 106 (44.5%) met the criteria for definite (n = 98) or possible (n = 8) PHACE syndrome. A stepwise linear regression model found that a surface area of 25 cm2 or greater (odds ratio [OR] 2.99; 95% CI, 1.49-6.02) and involvement of 3 or more locations (OR, 17.96; 95% CI, 6.10-52.85) to be statistically significant risk factors for PHACE syndrome. Involvement of the parotid gland (OR, 0.39; 95% CI, 0.18-0.85) and segment S2 (OR, 0.38; 95% CI, 0.16-0.91) was associated with a lower risk. Race and ethnicity may also be associated with PHACE syndrome risk, although more studies are needed. Conclusions and Relevance: This cohort study further described factors associated with both a higher and lower risk of PHACE syndrome. The presence of multiple anatomical sites and large surface area were associated with greater risk, whereas S2 or parotid IHs were associated with lower, but still potential, risk. These findings can help in counseling families and decision-making regarding evaluation of infants with large head and neck IHs.

5.
Pediatr Dermatol ; 37(5): 900-901, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32602155

ABSTRACT

Thermoplastic masks made of polyester resin are used to immobilize patients receiving radiation therapy. We describe a case of allergic contact dermatitis (ACD) to a thermoplastic mask worn by a child receiving proton beam therapy for treatment of medulloblastoma. ACD to a thermoplastic mask in an adult was first reported in 2018. (J Med Case Rep. 2018;12:181) To our knowledge, ACD to a thermoplastic mask has not been reported previously in the pediatric population.


Subject(s)
Dermatitis, Allergic Contact , Child , Dermatitis, Allergic Contact/diagnosis , Dermatitis, Allergic Contact/etiology , Humans , Immobilization , Masks
6.
Pediatr Dermatol ; 35(4): 494-497, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29766554

ABSTRACT

Primary cutaneous aspergillosis is a rare but potentially life-threatening disease. We present the case of a premature infant who developed primary cutaneous aspergillosis with Aspergillus niger at the site of a skin abrasion that had been treated with a purple-colored cyanoacrylate product. The infection was treated successfully with gentle debridement of the cyanoacrylate product, followed by intravenous voriconazole and topical fluconazole. To our knowledge, this is the first reported case of primary cutaneous aspergillosis occurring at the site of cyanoacrylate-based skin adhesive.


Subject(s)
Aspergillosis/diagnosis , Cyanoacrylates/adverse effects , Dermatomycoses/diagnosis , Adhesives/adverse effects , Antifungal Agents/therapeutic use , Aspergillosis/etiology , Aspergillosis/therapy , Debridement/methods , Dermatomycoses/therapy , Humans , Infant, Newborn , Infant, Premature , Male , Skin/microbiology , Skin/pathology
7.
Pediatr Dermatol ; 35(2): e103-e104, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29341221

ABSTRACT

We present what we believe to be the second case of pediatric penile porokeratosis and the youngest case reported. A 6-year-old boy presented with a pruritic, verrucous growth at the urethral meatus that recurred after two meatotomies. The diagnosis of porokeratosis was confirmed by biopsy. Porokeratosis should be added to the differential diagnosis of chronic hyperkeratotic penile lesions in children.


Subject(s)
Penis/pathology , Porokeratosis/diagnosis , Child , Diagnosis, Differential , Humans , Male , Urethra/pathology
8.
Pediatr Dermatol ; 34(5): 614-616, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28884920
9.
Pediatr Dermatol ; 34(6): e337-e340, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28940500

ABSTRACT

Orf is a zoonotic parapoxvirus typically transmitted to humans by a bite from goats or sheep. We present an unusual case of multiple orf lesions on the fingers of a 13-month-old child who was bitten by a goat and subsequently developed progressive swelling, blistering, and necrotic papulonodules of the hand followed by an additional diffuse, pruritic, papular rash. A primary diagnosis of orf infection was confirmed using real-time polymerase chain reaction, and the diffuse eruption was clinically consistent with an id reaction. Extensive necrosis and papular id reaction associated with orf rarely have been described.


Subject(s)
Dermatitis/virology , Ecthyma, Contagious/diagnosis , Animals , Bites and Stings , Dermatitis/drug therapy , Diphenhydramine/therapeutic use , Ecthyma, Contagious/drug therapy , Exanthema/etiology , Glucocorticoids/administration & dosage , Goats , Histamine H1 Antagonists/therapeutic use , Humans , Infant , Male , Orf virus , Real-Time Polymerase Chain Reaction , Skin/pathology , Skin/virology , Triamcinolone/administration & dosage
10.
Hum Mutat ; 34(12): 1632-41, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24038909

ABSTRACT

Capillary malformation-arteriovenous malformation (CM-AVM) is an autosomal-dominant disorder, caused by heterozygous RASA1 mutations, and manifesting multifocal CMs and high risk for fast-flow lesions. A limited number of patients have been reported, raising the question of the phenotypic borders. We identified new patients with a clinical diagnosis of CM-AVM, and patients with overlapping phenotypes. RASA1 was screened in 261 index patients with: CM-AVM (n = 100), common CM(s) (port-wine stain; n = 100), Sturge-Weber syndrome (n = 37), or isolated AVM(s) (n = 24). Fifty-eight distinct RASA1 mutations (43 novel) were identified in 68 index patients with CM-AVM and none in patients with other phenotypes. A novel clinical feature was identified: cutaneous zones of numerous small white pale halos with a central red spot. An additional question addressed in this study was the "second-hit" hypothesis as a pathophysiological mechanism for CM-AVM. One tissue from a patient with a germline RASA1 mutation was available. The analysis of the tissue showed loss of the wild-type RASA1 allele. In conclusion, mutations in RASA1 underscore the specific CM-AVM phenotype and the clinical diagnosis is based on identifying the characteristic CMs. The high incidence of fast-flow lesions warrants careful clinical and radiologic examination, and regular follow-up.


Subject(s)
Arteriovenous Malformations/diagnosis , Arteriovenous Malformations/genetics , Capillaries/abnormalities , Mutation , Phenotype , Port-Wine Stain/diagnosis , Port-Wine Stain/genetics , p120 GTPase Activating Protein/genetics , Amino Acid Substitution , DNA Mutational Analysis , Female , Gene Order , Genetic Association Studies , Humans , Male , Prospective Studies , Retrospective Studies
11.
Dermatol Ther ; 26(6): 462-6, 2013.
Article in English | MEDLINE | ID: mdl-24552409

ABSTRACT

Acne vulgaris is a common inflammatory skin condition affecting most individuals at some point during their lives. Although acne is more commonly seen in adolescents, it can be seen in younger patients as well. It can be useful to classify pediatric acne based on the age of presentation as infantile, mid-childhood, or preadolescent. We describe a practical approach to the evaluation and treatment of acne in each of these age groups.


Subject(s)
Acne Vulgaris/diagnosis , Acne Vulgaris/therapy , Child , Child, Preschool , Female , Humans , Infant , Male
12.
Curr Opin Pediatr ; 20(4): 436-40, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18622200

ABSTRACT

PURPOSE OF REVIEW: Acne vulgaris remains one of the most common conditions affecting adolescents. The pediatric practitioner is the first to evaluate adolescent acne, making familiarity with the condition and its management essential. This review covers some of the recent literature regarding acne to help practitioners stay current on the issues regarding this topic. RECENT FINDINGS: The pathogenesis of acne is multifactorial and complex, but recent advances in molecular genetics have provided additional information on the actions of Proprionibacterium acnes. Nutritional studies have reevaluated a possible role for diet and lifestyle factors in acne development. Many therapies are available to control acne and to limit associated scarring. Their appropriate use requires an understanding of not only the benefits but also the possible risks and adverse effects involved. Recent concerns regarding the use of antibiotics and isotretinoin will be addressed. SUMMARY: This study reviews the recent literature regarding teenage acne, focusing on pathogenesis, associations, and controversies and considerations in therapy.


Subject(s)
Acne Vulgaris/metabolism , Acne Vulgaris/therapy , Acne Vulgaris/etiology , Adolescent , Anti-Bacterial Agents/therapeutic use , Dairy Products/adverse effects , Dermatologic Agents/therapeutic use , Exercise/physiology , Glycemic Index , Humans , Isotretinoin/therapeutic use , Molecular Biology , Skin Care , Stress, Psychological/physiopathology , Sweating
13.
Dermatol Ther ; 18(2): 151-9, 2005.
Article in English | MEDLINE | ID: mdl-15953144

ABSTRACT

Hemangiomas of infancy are the most common tumors of childhood. They are clinically heterogeneous and as such require individualized treatment plans. Although there are no Food and Drug Administration (FDA)-approved agents for treatment of hemangiomas of infancy, there are many widely used therapeutic options available. This review highlights the treatments currently in use and the factors that direct treatment.


Subject(s)
Hemangioma/therapy , Neoplasms, Vascular Tissue/therapy , Hemangioma/diagnosis , Humans , Infant, Newborn , Neoplasms, Vascular Tissue/diagnosis
14.
J Am Acad Dermatol ; 51(5 Suppl): S194-6, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15577768

ABSTRACT

Factor V Leiden is the most common genetic thrombophilia in people of European descent, and is important to recognize as it can have significant implications in dermatology. We report a case of a 30-year-old man who presented for evaluation and treatment of a chronic ulceration on the site of his stump following a below the knee amputation which had been performed for non-healing ulcerations. Despite a variety of treatments, his ulcer persisted. He was referred to a dermatologist who performed a biopsy that was interpreted ass non-specific, and treatment was started for pyoderma gangrenosum. Further investigation revealed a homozygous factor V Leiden mutation and cryofibrinogenemia. He was tapered off of the methylprednisolone and was improving on stanozolol. He healed well after surgery and no new ulcerations have developed. This case highlights the importance of considering this mutation in a non-healing leg ulcer.


Subject(s)
Cryoglobulinemia/complications , Factor V/genetics , Leg Ulcer/etiology , Mutation , Adult , Amputation Stumps , Homozygote , Humans , Leg Ulcer/genetics , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...